| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| abbv-744 | bromodomain-containing protein 2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] Malignant neoplasm of prostate[MeSHID:D011471] |
2.36 | phase 1 | unknown |
| abbv-744 | bromodomain-containing protein 2 | NA | Clinical trial target | TTD , DGIDB | Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.36 | phase 1 | unknown |
| abbv-744 | bromodomain-containing protein 3 | NA | Clinical trial target | TTD , DGIDB | Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.65 | phase 1 | unknown |
| abbv-744 | bromodomain-containing protein 3 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] Malignant neoplasm of prostate[MeSHID:D011471] |
2.65 | phase 1 | unknown |
| abbv-744 | bromodomain-containing protein 4 | NA | Clinical trial target | TTD , DGIDB | Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.25 | phase 1 | unknown |
| abbv-744 | bromodomain-containing protein 4 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] Malignant neoplasm of prostate[MeSHID:D011471] |
1.25 | phase 1 | unknown |
| click here to return to the previous page | ||||||||